Reference:EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 Annex III 1.: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
gxplex>GxPlexBot Import from GxPlex Excel |
(No difference)
| |
Revision as of 15:06, 29 June 2026
| Document information | |
|---|---|
| Reference | EU Regulation (EU) No 520/2012 - performance of pharmacovigilance activities 20-Jun-12 |
| Validity area | EU |
| Scope(s) | G |
| Document name | Regulation (EU) No 520/2012 - performance of pharmacovigilance activities |
| Version / Revision | 20-Jun-12 |
| Status | Current |
| Document type | Regulatory requirement |
| Language(s) | EN |
| Description | Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council Text with EEA relevance
(Including NIS) |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Scope | G |
| Document part | Annex III
1. |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags (EN) | |
| Tags (original language) | |
| Tags (FR) | |
| Comment | PASS protocol, abstract and final study report requirements |
Content
ANNEX III
Protocols, abstracts and final study reports for post-authorisation safety studies
1. Format of the study protocol [...]
